Detalhe da pesquisa
1.
Safety and Efficacy of the NVX-CoV2373 Coronavirus Disease 2019 Vaccine at Completion of the Placebo-Controlled Phase of a Randomized Controlled Trial.
Clin Infect Dis
; 76(3): 398-407, 2023 02 08.
Artigo
Inglês
| MEDLINE | ID: mdl-36210481
2.
Safety of the NVX-CoV2373 COVID-19 vaccine in randomized placebo-controlled clinical trials.
Vaccine
; 41(26): 3930-3936, 2023 06 13.
Artigo
Inglês
| MEDLINE | ID: mdl-37211453
3.
Immunogenicity and safety of NVX-CoV2373 as a booster: A phase 3 randomized clinical trial in adults.
Vaccine
; 41(41): 5965-5973, 2023 09 22.
Artigo
Inglês
| MEDLINE | ID: mdl-37652823